Evidence map›Paper›PMID 30266767›Full record

ArticleJournal of immunology (Baltimore, Md. : 1950)2018

Short Leucine-Rich Proteoglycans Modulate Complement Activity and Increase Killing of the Respiratory Pathogen

Maisem Laabei, Guanghui Liu, David Ermert, John D Lambris, Kristian Riesbeck, Anna M Blom

Open access · bronzeAbstract read
In one paragraph

Article in Journal of immunology (Baltimore, Md. : 1950), 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.0field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 15 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Interaction ofMatrix biology plus · 2020
    Article
  10. Panel 7 - Pathogenesis of otitis media - a review of the literature between 2015 and 2019.International journal of pediatric otorhinolaryngology · 2020
    Review
  11. Antibacterial Fusion Proteins EnhanceFrontiers in immunology · 2020
    Article
  12. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 2 countries.

Maisem LaabeiDivision of Medical Protein Chemistry, Lund University, 21428 Malmö, Sweden.ORCID 0000-0002-8425-3704
Guanghui LiuDivision of Medical Protein Chemistry, Lund University, 21428 Malmö, Sweden.
David ErmertDivision of Medical Protein Chemistry, Lund University, 21428 Malmö, Sweden.ORCID 0000-0003-4600-9070
John D LambrisDepartment of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, PA 19104; and.ORCID 0000-0002-9370-5776
Kristian RiesbeckDivision of Clinical Microbiology, Department of Translational Medicine, Faculty of Medicine, Lund University, 21428 Malmö, Sweden.ORCID 0000-0001-6274-6965
Anna M BlomDivision of Medical Protein Chemistry, Lund University, 21428 Malmö, Sweden; Anna.Blom@med.lu.se.ORCID 0000-0002-1348-1734
Malmö University · SEUniversity of Pennsylvania · US

Funding

Role of complement in kidney disorders: from hemodialysis to transportationP01AI068730 · NIAID · UNIVERSITY OF PENNSYLVANIA · PI LAMBRIS, JOHN D · 2007 to 2018
$16.0M
NIAID NIH HHS P01 AI068730
6 · The paper itself

Abstract

The respiratory pathogen

Indexed as

Complement ActivationHost-Pathogen InteractionsHumansLeucineMoraxella catarrhalisMoraxellaceae InfectionsProteoglycansLeucineProteoglycans

Identifiers

PMID30266767
PMCPMC6200642
OpenAlexW2894035067

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.